On the fly News and insights, exclusive to thefly.com

APLS

Apellis

$46.16 /

+1.39 (+3.10%)

, DRNA

Dicerna

$29.17 /

+0.6 (+2.10%)

09:55
04/16/21
04/16
09:55
04/16/21
09:55

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Apellis (APLS) initiated with a Buy at Goldman Sachs. 2. Dicerna (DRNA) initiated with a Buy at Goldman Sachs. 3. Editas Medicine (EDIT) initiated with a Sell at Goldman Sachs. 4. Palomar (PLMR) assumed with an Overweight at JPMorgan. 5. Rush Street Interactive (RSI) initiated with a Buy at Jefferies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

APLS

Apellis

$46.16 /

+1.39 (+3.10%)

DRNA

Dicerna

$29.17 /

+0.6 (+2.10%)

EDIT

Editas Medicine

$37.35 /

-3.56 (-8.70%)

PLMR

Palomar

$73.23 /

-0.585 (-0.79%)

RSI

Rush Street Interactive

$14.86 /

+0.53 (+3.70%)

  • 14

    May

  • 10

    Jun

  • 24

    Jun

  • 24

    Jun

  • 21

    Jan

APLS Apellis
$46.16 /

+1.39 (+3.10%)

04/16/21 Goldman Sachs
Apellis initiated with a Buy at Goldman Sachs
04/14/21 Citi
Apellis year-to-date selloff brings 'very good entry point,' says Citi
03/29/21 JPMorgan
Apellis added to Analyst Focus List with $87 target at JPMorgan
01/29/21 Baird
Apellis assumed at Outperform at Baird
DRNA Dicerna
$29.17 /

+0.6 (+2.10%)

04/16/21 Goldman Sachs
Dicerna initiated with a Buy at Goldman Sachs
03/18/21
Dicerna to hold a webinar on DCR-AUD disorder
03/02/21 H.C. Wainwright
Dicerna price target raised to $40 from $35 at H.C. Wainwright
EDIT Editas Medicine
$37.35 /

-3.56 (-8.70%)

04/16/21 Goldman Sachs
Editas Medicine initiated with a Sell at Goldman Sachs
03/22/21 Credit Suisse
Editas Medicine initiated with an Outperform at Credit Suisse
03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
03/01/21 Barclays
Editas Medicine downgraded to Equal Weight from Overweight at Barclays
PLMR Palomar
$73.23 /

-0.585 (-0.79%)

04/16/21 JMP Securities
Palomar price target lowered to $95 from $105 at JMP Securities
04/16/21 JPMorgan
Palomar assumed with an Overweight at JPMorgan
03/26/21
Fly Intel: Top five analyst upgrades
03/26/21 Barclays
Palomar upgraded to Overweight from Equal Weight at Barclays
RSI Rush Street Interactive
$14.86 /

+0.53 (+3.70%)

04/16/21 Jefferies
Jefferies starts Rush Street Interactive at Buy with $21 price target
04/16/21 Jefferies
Rush Street Interactive initiated with a Buy at Jefferies
04/01/21 Credit Suisse
NY online sports betting likely to make it into budget, says Credit Suisse
03/23/21 Goldman Sachs
Rush Street Interactive price target raised to $25 from $23 at Goldman Sachs

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.